Reply to P-A Dugué et al.

Am J Clin Nutr

From the Department of Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, Netherlands.

Published: January 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171229PMC
http://dx.doi.org/10.1093/ajcn/nqz254DOI Listing

Publication Analysis

Top Keywords

reply p-a
4
p-a dugué
4
reply
1
dugué
1

Similar Publications

Reply to: Inferior Control Arms in Prostate Cancer Trials: The ARANOTE Trial.

J Clin Oncol

January 2025

Fred Saad, MD, University of Montreal, Montreal, QC, Canada; Egils Vjaters, MD, P. Stradinš Clinical University Hospital, Riga, Latvia; Isabella Testa, MD, Bayer S.p.A, Milan, Italy; and Kunhi Parambath Haresh, MD, All India Institute of Medical Sciences, New Delhi, India.

View Article and Find Full Text PDF

Reply.

J Allergy Clin Immunol

January 2025

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Ga. Electronic address:

View Article and Find Full Text PDF

Purpose: Electronic health records (EHRs) are valuable information repositories that offer insights for enhancing clinical research on breast cancer (BC) using real-world data. The objective of this study was to develop a natural language processing (NLP) model specifically designed to extract structured data from BC pathology reports written in natural language.

Methods: During the initial phase, the algorithm's development cohort comprised 193 pathology reports from 116 patients with BC from 2012 to 2016.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!